Target intelligence / Profile preview

Transfer RNA anticodon stem-loop (tRNA ASL)

Target
tRNA ASL
Molecular classification
Non-coding RNA, Transfer RNA, Ribonucleic acid structure
01

Overview

The transfer RNA (tRNA) anticodon stem-loop (ASL) is a fundamental structural component of tRNA molecules, essential for the accurate translation of mRNA into polypeptides. It consists of a seven-nucleotide loop containing the anticodon triplet, supported by a five-base-pair stem. The ASL's primary biological function is to recognize and bind to complementary mRNA codons within the ribosome's decoding center, a process heavily influenced by post-transcriptional modifications that enhance binding affinity and specificity (Agris et al., 2017). In clinical medicine, the ASL-ribosome interface is a major target for aminoglycoside antibiotics, which bind to the 16S rRNA and alter the conformation of the decoding site to favor the acceptance of near-cognate tRNA ASLs, resulting in lethal mistranslation in bacteria (Vicens & Westhof, 2003). Beyond infectious diseases, mutations in the ASL of mitochondrial tRNAs are implicated in severe metabolic disorders like MELAS, while aberrant ASL modification patterns are increasingly recognized as drivers of oncogenesis and neurological decline (Suzuki, 2021). Consequently, the ASL represents a sophisticated target for both traditional antimicrobial agents and emerging RNA-based precision therapies.

Other names
tRNA anticodon armAnticodon stem-loopASLtRNA decoding loop
02

Mechanism of action

Stabilization of the codon-anticodon interaction at the ribosomal A-site, leading to misreading of the genetic code and inhibition of protein synthesis.

03

Biological functions

Protein biosynthesisGenetic code decodingCodon-anticodon recognitionTranslational fidelityReading frame maintenance
04

Disease associations

Bacterial infectionMitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)Myoclonic Epilepsy with Ragged Red Fibers (MERRF)CancerNeurological disorders
05

Safety considerations

OtotoxicityNephrotoxicityMitochondrial toxicity due to structural similarity between bacterial and mitochondrial ribosomesPotential for global mistranslation in host cells
06

Interacting drugs

Gentamicin

6 more in the full profile.

07

Biomarkers

tRNA modification levels (e.g., m1G37, t6A37)tRNA-derived fragments (tRFs)Hypomodified tRNA species

Beyond the preview

Go deeper on Transfer RNA anticodon stem-loop (tRNA ASL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transfer RNA anticodon stem-loop (tRNA ASL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call